CPIX 8-K 2026-11-10

CUMBERLAND PHARMACEUTICALS INC (CPIX) 8-K dated 2026-11-10 — accession 0001087294-26-000076.

CUMBERLAND PHARMACEUTICALS INC (CPIX) is a drug manufacturers - specialty & generic company listed on US.

CPIX: CUMBERLAND PHARMACEUTICALS REPORTS

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported CPIX revenue for 2026-06-30 was $166.5K. Net income was -$4.3M. Revenue was down 98.2% from 2026-03-31 to 2026-06-30. CPIX currently screens at market cap $86.9M.

Not investment advice. The CPIX SEC hub lists recent forms. The stock page is the research view.